Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Infect Public Health ; 5(5): 360-5, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23164565

RESUMEN

OBJECTIVE: The aim of this study was to screen for diabetes mellitus in leprosy patients to elucidate whether leprosy infection may play a role in the pathogenesis of diabetes mellitus in this population. SUBJECTS AND METHODS: Thirty patients of different ages and of both sexes with various types of leprosy were included in this study. In addition, 15 healthy individuals of comparable age and sex who had no family history of diabetes mellitus were identified as controls. In both groups, determinations of fasting and postprandial blood sugar, an oral glucose tolerance test (OGTT), measures of fasting serum insulin and pro-inflammatory cytokine tumor necrosis factor alpha (TNFα), as well as calculations using the Homeostasis Model Assessment for Insulin Resistance (HOMA-IR), were carried out. RESULT: Approximately 13.3% of the leprosy patients were diabetic, and 37.7% were in pre-diabetic. The highest incidences of diabetes and pre-diabetes were in lepromatous leprosy (10% and 20%, respectively); a lower incidence of pre-diabetes (6.6%) was observed in tuberculoid leprosy; and the lowest incidence of diabetes (0.0%) was noted in borderline leprosy patients. Although normal healthy persons were not diabetic (0%), 20% were pre-diabetic. CONCLUSION: This study revealed that the incidence of diabetes was higher in the leprosy patients than in the control group. As a result, we recommend that all leprosy patients should be screened for diabetes.


Asunto(s)
Diabetes Mellitus/epidemiología , Diabetes Mellitus/etiología , Lepra/complicaciones , Adulto , Glucemia/análisis , Femenino , Prueba de Tolerancia a la Glucosa , Humanos , Incidencia , Insulina/sangre , Resistencia a la Insulina , Kuwait/epidemiología , Masculino , Persona de Mediana Edad , Factor de Necrosis Tumoral alfa/sangre , Adulto Joven
2.
Hansen. int ; 33(1): 35-40, 2008. ilus
Artículo en Portugués | LILACS, Sec. Est. Saúde SP, SESSP-ILSLPROD, Sec. Est. Saúde SP, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: lil-523081

RESUMEN

Paciente masculino, caucasiano, 49 anos, procedente do interior do estado de São Paulo, referiu estar em tratamento de hanseníase multibacilar há 2 meses, e que sua doença foi descoberta por meio de baciloscopia e biópsia de pele. Relatou que há 2 anos notou alteração de sensibilidade na parte distal lateral do pé esquerdo, associada a máculas eritematosas e hipocrômicas hipoestésicas no mesmo membro. Evoluiu com linfonodomegalia axilar e inguinal, placas eritematosas anulares bem delimitadas, disseminadas e dolorosas, algumas com ulceração central, além de nódulos dolorosos em membros, febre alta e mal estar geral. Internado em hospital geral, recebeu antibioticoterapia empírica, sem melhora do quadro, sendo então encaminhado para um infectologista que fez o diagnóstico de hanseníase na faixa virchowiana em reação. Iniciou tratamento com PQT-MB e prednisona, com melhora parcial das lesões, porém com desencadeamento de diabetes mellitus pelo corticoesteróide, e foi encaminhado para o Instituto Lauro de Souza Lima (ILSL). Na admissão, ao exame físico, além das placas, nódulos e discreta linfonodomegalia inguinal e axilar, o paciente não apresentava os sinais clássicos de hanseníase virchowiana, como infiltração difusa, madarose, desabamento nasal, perda de sensibilidade protetora em membros ou espessamento de nervos consistentes. O exame histopatológico do bordo de uma placa mostrou quadro de hanseníase na faixa virchowiana e reação Tipo 2 no derma superficial (eritema polimorfo hansênico), baciloscopia de 5+ (bacilos granulosos). A baciloscopia de pontos índices foi positiva em 6 pontos, 3 a 4 +, bacilos granulosos. A dosagem de IgM anti-PGL-1 (glicolipídeo fenólico 1) por ELISA foi de 0,241 e o teste ML-Flow (teste de fluxo lateral para o M. leprae) foi de 4+. O hemograma mostrou anemia importante (Ht=25%) e leucocitose com desvio a esquerda e granulações tóxicas, VHS 101mm. O exame bacteriológico colhido de uma lesão ulcerada revelou S. aureus coagulase...


A 49 years old white man comes from a city of the inner part of the state of São Paulo with the diagnosis of multibacillary leprosy under treatment for 2 months. He reported that 2 years before he noted loss of sensitivity on his left foot which was associated with several red and hypopigmented macules with disturbance of skin sensitivity. The disease evolved with axillary and inguinal lymphadenopathy, as well as tender sharp borders’ plaques and ill-defined nodules, some of then ulcerated, and high degree fever also occurred. He was then admitted into a general hospital, and empirical antibiotics were started, without improvement of symptoms. An evaluation by an infectologist was requested, and the diagnosis of reactional multibacillary leprosy was made after skin smears and skin biopsy were performed. Multibacillary multidrug therapy (MDT-MB) was started, as well as prednisone, with clinical improvement, but diabetes mellitus induced by prednisone occurred, and the patient was referred to the “Instituto Lauro de souza Lima” (ILSL). At admission, on the physical examination, other than the plaques, nodules and mild inguinal and axillary lymphadenopathy, the patient did not present classical findings of lepromatous leprosy, i.e., madarosis, difuse infiltration of skin, saddle nose, well-defined enlargement of periferal nerve trunks or even important disturbance of sensitivity on his limbs. Histopathologic examination of a skin biopsy collected from the border of a plaque showed leprosy on the lepromatous range with Type 2 reation, and the infiltrate was distributed mainly in the superficial dermis (erythema multiforme-like ENL), bacilloscopy 5+ (fragmented bacilli). Bacilloscopy of skin smears collected from index points was positive in all the 6 points, showing 3-4 +, with fragmented bacilli. ELISA for IgM anti-PGL-1 (phenolic glycolipid-1) was 0,241 and ML-Flow test (lateral flux test for M. leprae) was 4+. Hemogram showed severe anemia (Ht=26%)...


Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Eritema Nudoso , Lepra Multibacilar/diagnóstico , Lepra Multibacilar/terapia , Lepra Lepromatosa , Corticoesteroides/efectos adversos , Diabetes Mellitus/etiología , Eritema Multiforme , Colonias de Leprosos , Quimioterapia Combinada , Sistema Único de Salud
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA